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Tebuconazole is a widely used fungicide that has been detected in water ecosystems, of which the
concentrations may affect the endocrine function of aquatic organisms. At present study, tissue-speciﬁc
bioaccumulation of tebuconazole was found in ovary of adult zebraﬁsh, indicating a potential risk of
endocrine disruption. In order to evaluate the potential endocrine disrupting effects, three life stages (2
hpf (hours post-fertilization) 60 dpf (days post-fertilization), Stage I; 60e120 dpf, Stage II; 180e208 dpf,
Stage III) of zebraﬁsh (Danio rerio) were chronically exposed to tebuconazole at the concentrations
ranging from 0.05mg/L to 1.84mg/L. Result showed that exposed to tebuconazole could lead to a male-
biased sex differentiation in juvenile zebraﬁsh and signiﬁcant decrease of the percentage of germ cells in
sexually-mature zebraﬁsh. Egg production was signiﬁcantly inhibited by 57.8% and 19.2% after Stage II-
and Stage III-exposures, respectively. The contents of 17b-estradiol in gonad decreased by 63.5% when
exposed to 0.20mg/L tebuconazole at Stage II and by 49.5% after exposed to 0.18mg/L tebuconazole at
Stage III, respectively. For all stages exposure, reductions in 17b-estradiol/testosterone ratio were
observed, indicating an imbalance in steroids synthesis. Additionally, tebuconazole reduced the
expression of cyp19a, which was consistent with the decrease of E2 level. In overall, the present ﬁndings
indicated that, playing as an anti-estrogen-like chemical, tebuconazole inhibited the expression of Cyp19,
thereby impairing steroid hormones biosynthesis, leading to a diminished fecundity of zebraﬁsh.
© 2019 Elsevier Ltd. All rights reserved.CA, bicinchoninic acid; BCF,
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d Environmental Toxicology,1. Introduction
Tebuconazole is one of the most frequently used broad-
spectrum triazole fungicides in grains, vegetables and fruits
(Zhang et al., 2015). Due to its widespread application, tebucona-
zole can undergo runoff to surface water with the concentrations
ranging from 0.6 to 200 mg/L (Richardson and Kimura, 2007; Rabiet
et al., 2010; Zhang et al., 2015). Previous study demonstrated that
tebuconazole was persistent in soil, with a degradation half-life
(time required to reach 50% degradation) even reaching 600 days
(Cui et al., 2018). In Italy, evidence showed that the metabolites of
tebuconazole were detected in agricultural workers with the levels
ranging from 3 to 473 mg/L (Mercadante et al., 2014). These clearly
suggested that tebuconazole might pose risks to humans and
ecosystem at environmentally realistic concentrations.
Ecological toxicity of tebuconazole has been assessed over last
few years. For instance, exposed to 1.19mg/L tebuconazole reduced
growth, induced oxidative stress, and promoted metabolism of
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and triglycerides as well as vitellogenin were observed in male
zebraﬁsh after 14 days of tebuconazole exposure (Sancho et al.,
2010). Previous studies have determined thyroid disruption that
tebuconazole signiﬁcantly increased levels of triiodothyronine (T3)
by 27.8% and transcriptions of tshb and trb in zebraﬁsh by 2.18-fold
and 2.61-fold respectively after exposure for 120 dpf (Yu et al.,
2013). Similar thyroid toxicity was observed in amphibia. Meta-
morphosis of Hyla intermedia (Italia tree frog) was decreased by
58.0% and 73.9% after exposed to tebuconazole for 78 days at
concentrations of 5 and 50 mg/L, respectively (Bernabo et al., 2016).
Additionally, effects on reproduction following tebuconazole
exposure had been found in organisms. For example, in D. magna,
the reproduction rates decreased by 44% and 68% after exposed to
0.71mg/L tebuconazole for 14 and 21 days, respectively (Sancho
et al., 2015). An in vitro study showed that tebuconazole sup-
pressed functions of human placental trophoblast cell via protease
systems and hormones (Liu et al., 2015). 17b-estradiol (E2) levels
were suppressed in adult male Xenopus laevis after 27 days expo-
sures of 0.1, 1 and 100 mg/L tebuconazole (Poulsen et al., 2015).
Previous research reported that tebuconazole and other azole
compounds might cause endocrine disruption by inhibiting ste-
roids biosynthesis (Nellemann, 2010; Villeneuve et al., 2014). These
studies indicated that tebuconazole had potential risks to repro-
duction of different species. In general, reproductive and endocrine
impairments caused by tebuconazole have been reported in some
invertebrates and vertebrates. However, few study has been done
on the chronic effects of tebuconazole on gonadal development in
ﬁsh.
In the present study, using an aquatic model species, Danio rerio,
we aimed to validate the hypothesis that tebuconazole acted
through down-regulation of steroids (speciﬁcally E2) in aquatic
organisms and evaluate the linkage of its chronic exposurewith the
diminished reproduction of aquatic organisms. Since ﬁsh are often
exposed to environmental contaminants in their lifetime (involving
several life stages), to address these issues, the present study
characterized the effects caused by tebuconazole on zebraﬁsh in
three life stages: gonad forming and differentiating stage, gonad
undergoing to maturation stage and gonad maturated stage. To
conﬁrm the adverse outcome pathway (AOP) of tebuconazole-
mediated reproductive toxicity in zebraﬁsh, steroid hormones
including E2 and testosterone (T) were measured following tebu-
conazole exposure. To further explore the molecular mechanisms
potentially involved in tebuconazole toxicity, genes expressions of
estrogen receptor (esr), androgen receptor (ar), cytochrome P450
aromatase 17 (cyp17), cytochrome P450 side-chain cleavage
(cyp11a), 17b-hydroxysteroid dehydrogenase (hsd17b), 3b-hydrox-
ysteroid dehydrogenase (hsd3b), steroidogenic acute regulatory
protein (star), and protein expression of gonadal aromatase Cyp19a
(the protein of Cytochrome P450 Family 19 Subfamily A) were
evaluated.
2. Materials and methods
2.1. Chemicals and materials
Tebuconazole (CAS 107 534-96-3) standard (purity>98%) was
purchased from Shanghai Yuanji Chemical Co., Ltd. (Shanghai,
China). Tebuconazole stock solution (20 000mg/L) was prepared by
dissolving 5 g standard material in 250mL dimethyl sulfoxide
(DMSO) and stored at 20 C for no more than three months. A
series of given volumes of stock solution were diluted by embryo-
culture medium (ECM, containing 0.137M NaCl, 5.4mM KCl,
0.25mM Na2HPO4, 0.44mM KH2PO4, 1.3mM CaCl2, 1.0mM MgSO4
and 4.2mM NaHCO3) or charcoal ﬁltered tap water (DMSO as co-solvent, containing 0.01%, v/v) to form a set concentrations of
exposure solutions. Tricaine methanesulfonate (TMS) and DMSO
were obtained from Sigma (St. Louis, MO, USA). Lysis buffer,
bicinchoninic acid (BCA) protein kit, reference protein GAPDH
(glyceraldehyde 3-phosphate dehydrogenase) and HRP (horse
radish peroxidase)-conjugated secondary antibody (goat anti-
rabbit IgG antibody) were all purchased from Servicebio (Wuhan,
China). Methanol and acetonitrile were obtained from Merck
(Darmstadt, Germany).2.2. Zebraﬁsh maintenance
The cultivation of zebraﬁsh (AB strain, purchase from Institute of
Hydrobiology, Chinese Academy of Sciences) and artiﬁcial insemi-
nation of eggs were mainly performed according to the previous
studies (Wang et al., 2015a; Ma et al., 2016). Embryo, larvae and
adult ﬁsh were maintained as described in Supporting Information
(S1.1). All procedures were conducted in accordance with The
Guide for the Care and Use of Laboratory Animals (Council, 2010).2.3. Bioaccumulation and depuration
Adult zebraﬁsh of 4-month-age were exposed to 0.18mg/L ( 1100
LC50 (96 h) for adult zebraﬁsh) (Yu et al., 2013) tebuconazole so-
lution (containing 0.01% (v/v) DMSO) for 28 days (accumulation
phase), and the exposure solution was renewed at an interval of 3
days. Subsequently, the ﬁsh were transferred to tebuconazole-free
water and cultured for 21 days with daily renewal of water (dep-
uration phase). The test was conducted with 70 ﬁsh in a barrel-type
glass tank (Ø40 (i. d.) 40 cm) which ﬁlled with 35 L solution
(nearly 1 g bw/L). Zebraﬁsh in tebuconazole-free charcoal ﬁltered
tap water (containing 0.01% DMSO, v/v) was set as vehicle control
(VC). Each treatment was conducted in triplicates. During accu-
mulation phase, three ﬁsh per time were randomly sampled from
each tank at 1st, 2nd, 3rd, 5th,7th, 10th, 14th, 21st and 28th d after
exposure for whole-body-quantiﬁcation of tebuconazole, and ten
ﬁsh (at 28th d after exposure) were sampled and dissected to
separate the brain, gonad, liver and torso muscle for tissue-speciﬁc
bioaccumulation assessment. During depuration phase, three ﬁsh
per time were sampled from each tank at 1st, 2nd, 3rd, 5th, 7th,
10th, 14th and 21st d after depuration for whole-body-
quantiﬁcation of tebuconazole to evaluate the depuration effect.
During the whole 49-d period, the test system was maintained at
26± 1 C. The quantiﬁcation of tebuconazole in exposure solutions
and ﬁsh tissues were described in Supporting Information (S1.2).
Pseudo ﬁrst-order (Ofomaja et al., 2010) and ﬁrst-order kinetic
models were used to ﬁt the bioaccumulation and depuration ki-
netics of tebuconazole in zebraﬁsh, respectively. The pseudo ﬁrst-
order kinetic model was expressed via Eq. (1), while the ﬁrst-
order kinetic model was expressed via Eq. (2):
ln(Qe-Qt)¼ ln(Qe)-k1 t (1)
Qt¼Q0 e-k t (2)
Where Qe and Qt mean the accumulation concentrations of tebu-
conazole in zebraﬁsh (mg/kg) at equilibrium and at exposure or
depuration time t (d), respectively. Q0 means the initial concen-
tration of tebuconazole in zebraﬁsh (mg/kg) at the beginning of
depuration (or, in other words, at the end of exposure). The model
parameters k1 and k mean the pseudo ﬁrst-order uptake rate con-
stant (d1) and ﬁrst-order depuration rate constant (d1),
respectively.
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The chronic exposures were performed in three life stages of
zebraﬁsh. Stage I exposures were performed from 2 hpf (hours
post-fertilization) to 60 dpf (days post-fertilization). This duration
was selected because ﬁsh were undergoing gonadal sex differen-
tiation. Stage II exposures occurred from 60 to 120 dpf. This dura-
tion was selected because gonadal sex differentiation of ﬁsh was
ﬁnished and gradually undergoing to maturation. Stage III expo-
sures were conducted from 180 to 208 dpf. This duration was
selected because ﬁsh had already reached sexual maturity.
Stage I Exposure. Three hundred randomly selected embryos (2
hpf) were placed in a glass culture dish containing 60mL ECMwith
a given concentration of tebuconazole. Nominal exposure concen-
trations of tebuconazole were set as 0.05, 0.20 and 0.50mg/L
(represent 110 ingLC10,
1
4 LC10 and LC10 of embryo lethality, respec-
tively) (Yu et al., 2013), and tebuconazole-free solution (containing
DMSO, 0.01%, v/v) was set as VC. Each treatment was conducted in
triplicates. The exposure solution was renewed at an interval of
72 h during exposure (no renewal of exposure solution during 2 hpf
to 5 dpf), and dead embryos or larvae were removed after daily
observations. Additionally, beginning from 6 dpf, the exposure so-
lutions were prepared by charcoal ﬁltered tap water but not ECM,
and the ﬁsh from each repeat were termly transferred to bigger
glass tanks and cultured in different volumes of exposure solution
(0.5 L, 2 L and 5 L exposure solution when zebraﬁsh were in ages of
6e20, 21e40 and 40e60 dpf, respectively). After exposure, the ﬁsh
were sampled for sex appraisal by histological examination.
Stage II Exposure. The protocol was the same as Stage I expo-
sures except that 40 zebraﬁsh (60 dpf, unknown gender) with
uniform whole body length (WBL, 20± 2mm) and body weight
(BW, 50± 5mg) were selected and placed in a glass tank ﬁlled with
5 L exposure solution (different life stage using different volume of
exposure solution, i.e., 5 L, 20 L and 35 L exposure solution when
zebraﬁsh were in ages of 60e80, 81e100 and 101e120 dpf,
respectively). The nominal exposure concentrations of tebucona-
zole were also set as 0.05, 0.20 and 0.50mg/L. A self-made device
displayed in Fig. S1was used for themeasurement of body length of
zebraﬁsh at the beginning of exposures.
Stage III Exposure. The protocol was the same as Stage II ex-
posures except that 30 females and 30 males of 180 dpf old
zebraﬁsh (uniform WBL and BW of (39± 2) mm, (550± 55) mg for
female and (37± 2) mm, (400± 40) mg for male, respectively) were
selected and exposed in 35 L exposure solution lasting for 28 d at
concentrations of 0.18, 0.92 and 1.84mg/L tebuconazole (repre-
senting 1100 LC50,
1
20 LC50 and
1
10 LC50 of adult lethality, respectively)
(Yu et al., 2013). Each treatment was conducted in triplicates and
the exposure solution was renewed at an interval of 48 h.
At the end of each exposure stage, the collected ﬁsh were ﬁrstly
anesthetized by TMS (10mg/L) and measured for BW and WBL.
Subsequently, sex appraisal was conducted by histological exami-
nation for stage I and gender ratio (GR, male/female) was calcu-
lated. While for stage II and stage III, males and females (identiﬁed
by shape) in each tank were individually collected and ﬁsh with
same gender were randomly separated into two subgroups. For
each gender, ﬁsh (10 ﬁsh) from one subgroup were used for blood
collection (drawn from caudal vein) (Wang et al., 2015a) and hor-
mone measurement, and then the ﬁsh was dissected to separate
the gonad and the liver for the calculation of the gonadal somatic
index (GSI) and hepatic somatic index (HSI), respectively. The
separated gonads were then collected for mRNA analysis. Fish (10
ﬁsh) from another subgroup were directly dissected to separate the
ovary or testis for histological examination. The histological ex-
amination of gonadwas described in Supporting Information (S1.3).2.5. Quantiﬁcation of steroid hormones in tissues and plasma
Steroid hormones of E2 and T in plasma or whole body of
zebraﬁsh were quantiﬁed by a commercial enzyme-linked immu-
nosorbent assay (ELISA) kit (Cayman Chemical Company, MI, USA)
according to manufacturer's instructions, with the detection limits
of 19 pg/mL and 6 pg/mL for E2 and T, respectively. Each samplewas
analyzed in 3-well replicates in a same plate with a coefﬁcient of
variation less than 20%.
2.6. Quantitative Real-Time PCR assay
The total RNA was extracted using TRIzol reagent as described
by Li et al. (2016). RNA extraction and gene expression analysis
were conducted as described in the Supporting Information (S1.4).
Quantitative Real-Time PCR (qRT-PCR) was performed to examine
the selected genes (cyp11a,cyp17a, cyp19a, esr1,esr2b, star, hsd3b1,
hsd17b1 and hsd17b3) in HPG (hypothalamic-pituitary-gonadal)
axis and the primer sequences (Table S3) of those genes were
performed as previously described (Wang et al., 2015b; Ma et al.,
2016).
2.7. Cyp19a western blot analysis
Cyp19a in gonad of ﬁsh was selected to analysis of its protein
expression level at the end of Stage II exposure. A western blot was
performed by using 3 ovaries or 3 testes from each replicate. After
0.3mL ice cold Lysis buffer was added, selected tissues were ho-
mogenized with IKA T10 (Staufen im Breisgau, Germany) at
8000 rpm (runs per minute) for 1min. Then the content of total
protein for each tissue lysate was determined by BCA protein kit.
Each protein sample was electrophoresed in a 12.5% (m/m) SDS-
polyacrylamide gel, using a Mini-Protean Tetra Cell apparatus
(Bio-Rad, Hercules, CA, USA). After that, the proteins were trans-
ferred to PVDF (polyvinylidene ﬂuoride) membrane (Darmstadt,
Germany) and blocked with 5% (m/v) fat-free milk for 1 h at room
temperature. The membrane was washed and further incubated at
room temperature for 3 h with primary rabbit anti-Cyp19a anti-
body (1:1000, v/v) (Abcam, USA) or reference protein (GAPDH,
1:10 000, v/v), and the blots were developed with HRP-conjugated
secondary antibody (1:3000, v/v) and visualized by enhanced
chemiluminescence. The relative optical density of protein
imprinting band was analyzed using Image Lab 5.2 Software (Bio-
Rad, USA). A quantitative measure of protein expression was ob-
tained by densitometry, with the results normalized to GAPDH
expression.
2.8. Statistical analysis
Statistical analysis was performed using SPSS® version 20.0
(SPSS, USA). The data were initially veriﬁed for normality and ho-
mogeneity of variance using the Kolmogorov-Smirnov test and
Levene's test. Data were expressed as means± standard deviation
(SD). Statistical differences in BW, WBL, gene expression and ste-
roids concentrations were evaluated by one-way analysis of vari-
ance (ANOVA) followed by Tukey's test to the p-values. A p-value
<0.05 was considered statistically signiﬁcant.
3. Results
3.1. Accumulation and depuration of tebuconazole in zebraﬁsh
After 28 days of exposure, the average concentration of tebu-
conazole measured in the exposure mediumwas 0.177± 0.013mg/
L with a ﬂuctuation of 0.153e0.197mg/L (Fig. S2). The maximum
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which conformed to the requirements of OECD (Organization for
Economic Cooperation and Development) Guideline 203 (OECD,
1992). In ﬁsh, the content of tebuconazole gradually increased,
and reached a steady-state on 21st d after exposure with the
equilibrium concentration of 3.859± 0.301mg/kg (Fig. 1A). The
measured bioconcentration factor (BCF, the ratio of equilibrium
concentration of tebuconazole in ﬁsh to exposure concentration of
tebuconazole in water) was approximately 21.8, indicating mod-
erate accumulation (China, 2014). Meanwhile, the contents of
tebuconazole in liver, gonad, brain and muscle on 28th d after
exposure were 5.711± 0.212, 3.459± 0.323, 0.374± 0.041 and
2.503± 0.094mg/kg, respectively (Fig. 1B). The cumulative curve of
tebuconazole in zebraﬁsh ﬁtted the pseudo-ﬁrst-order dynamic
model (R2¼ 0.984) with calculated Qe values of 3.794mg/kg and k1
of 0.2127 d1, respectively (Fig. 1C).
In the depuration phase, the maximum cumulative mortality of
remaining zebraﬁsh was 6.7% (including control groups and dep-
uration groups). The content of tebuconazole in zebraﬁsh slowly
decreased from 3.859± 0.301mg/kg (at the end of exposure) to
1.997± 0.168mg/kg (on 21st day after depuration) (Fig. 1A). The
depuration curve ﬁtted the ﬁrst-order dynamic model (Qt¼ 3.908
e0.0301t, R2¼ 0.9752). The DT50 and DT95 (time required to reach
50% and 95% disappearance of tebuconazole in ﬁsh, respectively)
were 23.0 d and 100.4 d, respectively. The depuration rate constant
(k) was 0.0301 d1 (Fig. 1D).
3.2. Developmental and reproductive toxicity of tebuconazole to
zebraﬁsh
The survival rates (SRs) of ﬁshwere higher than 80%whatever inFig. 1. Accumulation/depuration dynamics and tissue-depend distribution of tebuconazole in
depend distribution of tebuconazole in zebraﬁsh; (C) The pseudo-ﬁrst-order dynamic curv
depuration of tebuconazole in zebraﬁsh. The letters a,b,c,d represented signiﬁcant differenStage II exposures or in Stage III exposures, while it was slightly
lower in Stage I exposures (ranging from 68.0% to 74.9%). However,
the corrected mortalities of ﬁsh in all groups were lower than 10%.
Additionally, at a same exposure stage, there was no signiﬁcant
difference in SR or corrected mortality (CM) among treatments.
Moreover, result showed that exposed to tebuconazole at three life
stages of zebraﬁsh all resulted in developmental and reproductive
toxicities. Data were detailedly listed in Table 1.
Overall, tebuconazole had a negative effect on BW of zebraﬁsh.
Compared with VC, signiﬁcant decrease of BWe (body weight at the
end of exposure) at Stage I exposures was only found in 0.05mg/L
treatment (reducing by 32.6%, p¼ 0.036). For Stage II exposures, the
BW of ﬁsh for all groups increased 5.27- to 8.31-fold from the
beginning to the end of exposures. However, general decreases of
BWe were found in all tebuconazole treatments, and signiﬁcance
decrease occurred in 0.20mg/L treatment whatever for female
(reducing by 26.0%, p¼ 0.001) or male (reducing by 23.3%,
p¼ 0.004). Similar variations of BWe were both found in male and
female ﬁsh in Stage III exposures. After treated with 0.18, 0.92 and
1.84mg/L of tebuconazole, BWe were 419.5± 20.8mg (p> 0.05),
386.0± 16.3mg (p¼ 0.018), 392.5± 19.2mg (p¼ 0.043) for males
and 55.6± 40.3mg (p> 0.05), 466.9± 30.2mg (p¼ 0.037), and
461.9± 28.4mg (p¼ 0.032) for females respectively. While in VC,
BWe for male and female ﬁsh were 434.1± 13.6mg and
570.0± 44.9mg, respectively. Additionally, compared with BWi
(bodyweight at the initial time of exposure), slight variations of BW
which could be ignored were found in VC and 0.18mg/L groups
(BWe/BWi, 0.98- to1.05-fold, p> 0.05), while signiﬁcant decreases
of BW of female ﬁsh in 0.92 and 1.84mg/L groups (0.87-fold
(p¼ 0.041) and 0.83-fold (p¼ 0.018), respectively) and male ﬁsh
in 1.84mg/L group (0.90-fold (p¼ 0.045)) were observed.zebraﬁsh. (A) Accumulation-depuration curve of tebuconazole in zebraﬁsh; (B) Tissue-
e for accumulation of tebuconazole in zebraﬁsh; (D) The ﬁrst-order dynamic curve for
ce among tissues (p < 0.05).
Table 1
Developmental and reproductive toxicities of tebuconazole to zebraﬁsh.
Exposure stage Toxicity index Treatment a
VC L M H
Stage I SR b (%) 74.7± 3.2 74.9± 3.8 71.9± 2.2 68.0± 9.3
CM c (%) / 0.3 3.7 8.9
BWe d (mg) female 49.4± 7.0 53.2± 5.5 42.8± 6.3 33.3 ± 4.4*
BWe (mg) male 45.2± 2.3 44.5± 2.6 40.1± 3.1 31.2 ± 4.9*
WBLe e (mm) female 18.8± 0.1 19.3± 0.5 17.6± 0.7 16.7 ± 0.6*
WBLe (mm) male 18.0± 0.4 16.9± 0.4 16.8± 0.7 15.7± 1.3
Stage II BWi f (mg) 50.9± 4.0 48.6± 2.7 52.4± 2.9 50.5± 3.9
WBLi g (mm) 19.3± 0.3 18.6± 0.5 18.9± 0.4 18.4± 0.6
SR (%) 86.2± 6.9 84.4± 4.2 87.8± 7.5 87.5± 5.8
CM (%) / 2.12 1.84 1.50
BWe (mg) female (Fold of change, BWe/BWi) 421.8± 14.8 (8.29) 403.8± 25.3 (8.31) 312.3 ± 29.0** (5.96) 406.1± 24.4 (8.04)
BWe (mg) male (Fold of change, BWe/BWi) 360.0± 37.3 (7.07) 329.2± 60.4 (6.77) 276.2 ± 19.1** (5.27) 335.9± 39.1 (6.65)
WBLe (mm) female 39.4± 2.1 35.9 ± 0.5* 32.4 ± 0.1** 36.3± 7.9
WBLe (mm) male 38.0± 1.2 35.0± 2.6 32.4 ± 1.2*** 35.3 ± 1.9*
HSIh (%) female 1.92± 0.09 1.31 ± 0.16** 1.63± 0.38 1.47± 0.72
HSI (%) male 0.90± 0.11 0.73± 0.31 1.09± 0.27 0.95± 0.37
GSIi (%) female 12.15± 0.53 10.93± 1.73 10.92± 3.21 10.49 ± 0.32**
GSI (%) male 1.90± 0.17 1.29± 0.57 0.97 ± 0.38*** 1.62 ± 0.21*
EP j (eggs per female) 49.3± 5.5 41.6± 1.1 20.5 ± 5.2** 20.8 ± 2.1**
Stage III BWi (mg) female 543.3± 53.0 545.9± 41.1 534.7± 25.7 554.3± 22.2
BWi (mg) male 421.9± 15.2 428.5± 36.2 418.2± 21.5 434.6± 9.2
WBLi (mm) female 39.6± 1.3 39.2± 1.1 39.5± 1.3 40.0± 1.7
WBLi (mm) male 37.9± 1.5 36.7± 1.6 36.9± 1.1 37.1± 1.8
SR (%) female þ male 95.6± 2.5 94.4± 2.5 92.9± 1.9 88.9± 4.2
CM (%) female þ male / 1.2 2.9 7.0
BWe (mg) female (Fold of change, BWe/BWi) 570.0± 44.9 (1.05) 555.6± 40.3 (1.02) 466.9 ± 30.2*# (0.87) 461.9 ± 28.4*# (0.83)
BWe (mg) male (Fold of change, BWe/BWi) 434.1± 13.6 (1.03) 419.5± 20.8 (0.98) 386.0 ± 16.3* (0.92) 392.5 ± 19.2*# (0.90)
WBLe (mm) female 40.7± 1.5 39.5± 0.7 38.3± 1.3 38.8± 1.2
WBLe (mm) male 39.0± 1.3 37.5± 1.5 37.3± 1.0 37.8± 2.4
HSI (%) female 2.25± 0.18 2.32± 0.26 1.85 ± 0.13* 1.73 ± 0.09*
HSI (%) male 1.85± 0.14 1.62± 0.15 1.45 ± 0.12* 1.38 ± 0.21*
GSI (%) female 11.83± 0.55 11.31± 1.36 10.31 ± 0.62* 9.87 ± 0.74*
GSI (%) male 1.64± 0.15 1.64± 0.18 1.36± 0.16 1.32 ± 0.11*
EP (eggs per female) 92.7± 4.7 86 ± 4.4 74.3 ± 6.5** 71.6 ± 7.9*
*p < 0.05 and **p< 0.01 indicates signiﬁcant differences between exposure groups and the corresponding vehicle control group.
a VC means vehicle control. L means 0.05mg/L treatment for Stages I and II exposure, and 0.18mg/L treatment for Stage III exposure. M means 0.20mg/L treatment for
Stages I and II exposure, and 0.90mg/L treatment for Stage III exposure. H means 0.50mg/L treatment for Stages I and II exposure, and 1.84mg/L treatment for Stage III
exposure.
b SR means survival rate.
c CM means corrected mortality.
d BWe means body weight of ﬁsh at the end of exposure.
e WBLe means whole body length of ﬁsh at the end of exposure.
f BWi means body weight of ﬁsh at the initial time of exposure.
g WBLi means whole body length of ﬁsh at the initial time of exposure.
h HSI¼ liver weight/body weight 100; i GSI¼ gonad weight/body weight 100.
j EP means egg production. All the data are expressed as the mean± SD.
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zebraﬁsh were also observed. For Stage I, signiﬁcant decrease of
WBLe (whole body length at the end of exposure) occurred in
0.50mg/L treatment. While for Stage II, there was no signiﬁcant
difference of WBLi (whole body length at the initial time of expo-
sure) among different treatments. However, compared with VC,
signiﬁcant decreases of WBLe of female ﬁsh were found in all three
exposure groups and male ﬁsh in 0.20 and 0.50mg/L groups. There
was no signiﬁcant change in WBLe for both male and female ﬁsh
among treatments after Stage III exposures.
The effects of tebuconazole on HSI and GSI of zebraﬁsh were
only performed at the end of stage II and stage III exposures
because the liver and gonad of zebraﬁsh at the end of stage I
exposurewere too small to be separated. Generally weak inhibition
of tebuconazole on HSI for stage II exposure ﬁsh was found, and
signiﬁcant decrease of which was only occurred in 0.05mg/L group
for female ﬁsh (1.31± 0.16, p¼ 0.001). Comparatively, strong
inhibitory effect of tebuconazole on HSI was found after Stage III
exposures, and signiﬁcant decreases were found in 0.92 and
1.84mg/L groups both for male and female ﬁsh. Signiﬁcantreductions in GSI were observed for female in groups of 0.50mg/L
(Stage II, 10.49 ± 0.32, p¼ 0.004), 0.92mg/L (Stage III, 10.31± 0.62,
p¼ 0.035) and 1.84mg/L (Stage III, 9.87± 0.74, p¼ 0.034) and male
in groups of 0.20mg/L (Stage II, 0.97± 0.38, p< 0.001) and 0.5mg/L
(Stage II, 1.62± 0.21, p¼ 0.034) and 1.84mg/L (Stage III, 1.32± 0.11,
p¼ 0.044).
Tebuconazole could greatly inhibit the fecundity of zebraﬁsh.
Compared with VC (49.3± 5.5 eggs per female (epf) for Stage II and
92.7± 4.7 epf for Stage III), exposed to tebuconazole, egg produc-
tion (EP) signiﬁcantly reduced by 58.4% (20.5± 5.2 epf, p¼ 0.019)
and 57.8% (20.8± 2.1 epf, p¼ 0.023) in 0.20 and 0.50mg/L groups of
Stage II, 19.8% (74.3± 6.5 epf, p¼ 0.007) and 22.8% (71.6± 7.9 epf,
p¼ 0.024) in 0.92 and 1.84mg/L groups of Stage III, respectively.3.3. Histological examination
Gonadal histological examination of zebraﬁsh was carried out to
observe the pathological change and the development of germ cell
after Stage II and Stage III exposures. Due to too small of gonad of
zebraﬁsh at 60 dpf to be separated, histological examination was
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exposure to identify the gender and then calculate GR. Result
showed that obvious pathological change was occurred neither in
ovary nor in testis of zebraﬁsh for all treatments (Fig. S3, S4 and S5).
However, tebuconazole obviously disrupted the sex differentiation
of zebraﬁsh in Stage I. After exposed to 0.05, 0.20 and 0.50mg/L
tebuconazole, GR were 1.18± 0.23 (p¼ 0.853), 1.61± 0.16
(p¼ 0.038) and 4.04 ± 0.88 (p¼ 0.025), respectively. While in VC
group, GRwas 1.15± 0.20. Data showed that GR gradually increased
accompanyingwith the rising of exposure concentration, indicating
that tebuconazole plays as an androgen-like or antiestrogen-like
chemical (Fig. 2A).
For stage II, no signiﬁcant difference was found in GR after
exposure (data not shown) due to the sex differentiation of the
zebraﬁsh used had already ﬁnished at the beginning of exposureFig. 2. Effects of tebuconazole on the development of germ cells of zebraﬁsh after (A) sta
exposures. PO, primary oocytes; CAO, cortical alveolar oocytes; EVO, early vitellogenic oo
cytes; Sg, spermatogonia.(Santos et al., 2017). But ovarian and testicular histology both
showed signiﬁcant differences in developing degree of germ cells,
i.e., exposed to tebuconazole caused variation in the proportion of
primary oocytes (PO), cortical alveolar oocytes (CAO), early vitel-
logenic oocytes (EVO) and late/mature oocytes (LMO) in female and
spermatozoa (Sz), spermatocytes (Sc) and spermatogonia (Sg) in
male, respectively. In ovary, compared with VC, the percentages of
LMO signiﬁcantly decreased by 57.4% (p< 0.001), 44.1% (p¼ 0.007)
and 32.7% (p¼ 0.048) after exposure to tebuconazole at 0.05, 0.20
and 0.50mg/L, respectively. Meanwhile, in all three exposure
groups the proportions of CAO increased by 148.4% (p¼ 0.004),
246.8% (p< 0.001), 140.3% (p¼ 0.023), respectively (Fig. 2B). In
testis, compared with VC, the percentages of Sc in 0.05mg/L and
0.50mg/L exposure groups signiﬁcantly reduced by 53.8%
(p< 0.001) and 38.4% (p¼ 0.014), respectively. Moreover, thege I, (B) stage II -female, (C) stage II-male, (D) stage III-female and (E) stage III-male
cytes; LMO, late/mature oocytes; AO, Atreticoocyte; Sz, spermatozoa; Sc, spermato-
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(p< 0.001) and 36.1% (p< 0.001) in 0.05, 0.20 and 0.50mg/L tebu-
conazole treatments, respectively. In contrast, the percentages of Sg
increased by 498.2% (p< 0.001), 368.4% (p¼ 0.029) and 419.5%
(p¼ 0.001), respectively (Fig. 2C).
Similar results were found in ovary of female ﬁsh at the end of
stage-III exposure. Compared with VC, the percentages of LMO
decreased by 10.8% (p¼ 0.093), 7.3% (p¼ 0.068) and 13.9%
(p¼ 0.011), while CAO conversely increased by 57.5% (p¼ 0.101),
176.7% (p< 0.00.001) and 167.1% (p < 0.001) after exposed to
tebuconazole at 0.18, 0.92 and 1.84mg/L, respectively (Fig. 2D). In
testis of stage-III exposed male ﬁsh, compared with VC, there was
no signiﬁcant variation in portions of Sg, Sc and Sz in low con-
centration (0.18mg/L) of tebuconazole treatment. But signiﬁcant
variations of those were found in high concentration (1.84mg/L) of
tebuconazole treatment, in which Sc signiﬁcantly increased by
81.2% (p< 0.001, from 14.6% (VC) to 26.4%), Sg and Sz signiﬁcantly
reduced by 17.0% (p¼ 0.014, from 46.3% (VC) to 38.4%) and 10.1%
(p¼ 0.003, from 39.1% (VC) to35.2%) respectively (Fig. 2E).
3.4. Effects of tebuconazole on sex hormones of zebraﬁsh
The effects of different concentrations of tebuconazole on the
expression of sex hormones (T and E2) in plasma of zebraﬁsh were
conducted after exposure and the folds of change (FCs) for T, E2 or
E2/T ratio (all compared with VC) were calculated (Fig. 3). For fe-
male ﬁsh (Fig. 3A), the FCs of T and E2 in plasma displayed opposite
variation tendencies at the end of stage I exposures. Generally, FC of
T increased (1.14 (p> 0.05), 1.56 (p< 0.05) and 1.92 (p< 0.05) in
0.05, 0.20 and 0.50mg/L groups, respectively) while those of E2
decreased (0.88 (p> 0.05), 0.64 (p< 0.05) and 0.51 (p< 0.05) in
0.05, 0.20 and 0.50mg/L groups, respectively), giving a positive and
a negative dose-response relationship with tebuconazole, respec-
tively. Similar results were obtained for FCs of T and E2 at the end of
stage II exposures, but no dose-response relationship was found
(1.09 (p> 0.05), 1.04 (p> 0.05) and 1.39 (p< 0.05) for FC of T and
0.77 (p> 0.05), 0.24 (p< 0.05) and 0.36 (p< 0.05) for FC of E2 in
0.05, 0.20 and 0.50mg/L groups, respectively). No signiﬁcant
alternation was observed for FC of T in Stage III groups (0.78
(p> 0.05), 1.03 (p> 0.05) and 1.09 (p> 0.05) in 0.05, 0.20 and
0.50mg/L groups, respectively), but those of E2 reduced signiﬁ-
cantly in all three exposure treatments (0.67 (p< 0.05), 0.69
(p< 0.05) and 0.44 (p< 0.05) in 0.05, 0.20 and 0.50mg/L groups,
respectively). For male ﬁsh (Fig. 3B), the variations of T and E2 were
very closed to those of females. Additionally, the ratio of E2/TFig. 3. Inﬂuence of tebuconazole on the expression of sex hormones T and E2 in (A) female an
H meant low, medium and high concentrations of tebuconazole, representing 0.05, 0.20 and
respectively.generally went down accompanying with the increase of tebuco-
nazole in all three exposure stages, whatever in females or inmales.
It indicated that tebuconazole could inhibit the synthesis of E2 and
promote the content of T, leading to the disorders of sex hormones
in zebraﬁsh.
3.5. Inﬂuence of tebuconazole on HPG axis-related genes expression
of zebraﬁsh
The expression of genes associatedwith HPG-axis were assessed
in zebraﬁsh exposed to tebuconazole at all stages (Fig. 4).
After stage I exposures, in female ﬁsh (Fig. 4A), the expression of
cyp19awas diminished in 0.20 (0.58-fold, p¼ 0.027) and 0.50mg/L
(0.59-fold, p¼ 0.005) groups. Decreases in mRNA expression of esr1
(0.40-fold, p¼ 0.002; 0.63-fold, p¼ 0.023; 0.43-fold, p¼ 0.003) and
hsd17b1 (0.30-fold, p¼ 0.002; 0.39-fold, p¼ 0.010; 0.29-fold,
p¼ 0.001) were observed in 0.05, 0.20 and 0.50mg/L tebuconazole
treatments in females. Transcripts of esr2b were signiﬁcantly
reduced in 0.05 (0.34-fold, p¼ 0.001) and 0.50mg/L (0.65-fold,
p¼ 0.012) tebuconazole treatments of female ﬁsh. In contrast,
Transcripts of hsd3b1 (1.67-fold, p¼ 0.007; 1.80-fold, p¼ 0.033) and
cyp11a (1.79-fold, p¼ 0.027; 1.53-fold, p¼ 0.016) in females were
signiﬁcantly increased in 0.20 and 0.50mg/L tebuconazole treat-
ments. Inmale zebraﬁsh (Fig. 4B), after stage I exposures, themRNA
expression of esr1 and esr2b were diminished in all tebuconazole
treatments. The FCs were 0.36-fold (p¼ 0.002), 0.36-fold
(p¼ 0.003) and 0.43-fold (p¼ 0.014) for esr1, and 0.28-fold
(p¼ 0.002), 0.35-fold (p¼ 0.003) and 0.32-fold (p¼ 0.009) for
esr2b in 0.05, 0.20 and 0.50mg/L tebuconazole treatments,
respectively. The transcripts of cyp19a, hsd17b1 and hsd17b3 were
decreased while hsd3b1 was contrarily increased in 0.50mg/L
tebuconazole treatment in male ﬁsh. The FCs were 0.68-fold
(p¼ 0.003), 0.61-fold (p¼ 0.002), 0.46-fold (p¼ 0.001) and 1.97-
fold (p¼ 0.010) for cyp19a, hsd17b1, hsd17b3 and hsd3b1,
respectively.
After stage II exposures, in female ﬁsh (Fig. 4C), transcripts of
esr1 were signiﬁcantly down-regulated in 0.20 and 0.50mg/L
tebuconazole treatments (0.71-fold (p¼ 0.023) and 0.77-fold
(p¼ 0.019), respectively). Transcript of esr2b was signiﬁcantly
reduced in 0.50mg/L tebuconazole treatment (0.70-fold,
p¼ 0.042). In 0.20 and 0.50mg/L tebuconazole treatments, the
transcripts of cyp19a were signiﬁcantly decreased but cyp11a, star
and hsd3b1 were signiﬁcantly up-regulated, with the FCs of 0.71-
fold (p¼ 0.018) and 0.55-fold (p¼ 0.036) for cyp19a, 1.50-fold
(p¼ 0.026) and 1.75-fold (p¼ 0.013) for cyp11a, 2.28-foldd (B) male zebraﬁsh exposed to different life stages. VC meant vehicle control; L, M and
0.5mg/L for Stage I and II exposures, and 0.18, 0.92 and 1.84mg/L for Stage III exposure,
Fig. 4. Inﬂuence of tebuconazole on HPG-axis related gene expression in female and male ﬁsh after three stage exposures. (A) Stage-I, female ﬁsh, (B) Stage-I, male ﬁsh, (C) Stage-II,
female ﬁsh, (D) Stage-II, male ﬁsh, (E) Stage-III, female ﬁsh and (F) Stage-III, male ﬁsh. *p < 0.05, **p < 0.01, and ***p< 0.001, indicating signiﬁcant differences between exposure
groups and the corresponding control group.
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(p¼ 0.006) and 2.12-fold (p< 0.001) for hsd3b1, respectively.
Decrease of hsd17b1 mRNA expression (0.82-fold, p¼ 0.026) was
observed in 0.05mg/L tebuconazole treatment. In male zebraﬁsh
(Fig. 4D), transcripts of esr1 were signiﬁcantly down-regulated in
0.20 and 0.50mg/L tebuconazole treatments (0.54-fold (p¼ 0.030)
and 0.40-fold (p¼ 0.007), respectively). The mRNA expressions of
cyp19a were signiﬁcantly decreased in all tebuconazole exposure
groups. General decreases of hsd17b1mRNA expressionwere found
in all tebuconazole treatments, but signiﬁcances only occurred in
0.05 and 0.20mg/L treatments. The mRNA expression of ar (1.97-
fold, p¼ 0.020), star (1.82-fold, p¼ 0.011), cyp11a (4.80-fold,
p¼ 0.003) and hsd3b1 (2.90-fold, p¼ 0.023) were signiﬁcantly
increased in 0.50mg/L tebuconazole treatment.
At stage III, gonadal transcripts of esr2b and hsd17b1 as well as
star in females were signiﬁcantly decreased in 0.18mg/L (0.58-fold
(p¼ 0.022), 0.36-fold (p¼ 0.009) and 0.46-fold (p¼ 0.009),
respectively) and 0.92mg/L (0.39-fold (p¼ 0.002), 0.47-fold
(p¼ 0.007) and 0.13-fold (p¼ 0.003), respectively) tebuconazole
treatments (Fig. 4E). Signiﬁcant diminished transcripts of cyp17a
and cyp19a in females occurred in 0.18, 0.92 and 1.84mg/L treat-
ments, with the FCs of 0.53-fold (p¼ 0.025), 0.58-fold (p¼ 0.013)and 0.64-fold (p¼ 0.023) for cyp17a, and 0.49-fold (p¼ 0.002),
0.26-fold (p< 0.001) and 0.54-fold (p¼ 0.012) for cyp19a, respec-
tively. Transcripts of ar increased in 0.92mg/L treatment (2.9-fold,
p¼ 0.021), but reduced in 0.18mg/L group (0.32-fold, p¼ 0.007).
Transcription of hsd3b1 in females was enhanced 1.78-fold
(p¼ 0.032) in 0.18mg/L tebuconazole group. In male ﬁssSeven
transcripts of esr1, esr2b, cyp11a, cyp17a, cyp19a, hsd17b1 and
hsd17b3were signiﬁcantly down-regulated in both 0.18mg/L group
(0.27-fold (p¼ 0.001), 0.32-fold (p< 0.001), 0.36-fold (p¼ 0.006),
0.40-fold (p¼ 0.034), 0.27-fold (p¼ 0.008), 0.46-fold (p< 0.001)
and 0.22-fold (p< 0.001), respectively) and 0.92mg/L group (0.04-
fold (p¼ 0.005), 0.59-fold (p¼ 0.027), 0.37-fold (p¼ 0.007), 0.12-
fold (p¼ 0.013), 0.03-fold (p¼ 0.003), 0.04-fold (p< 0.001) and
0.03-fold (p< 0.001), respectively). In contrast, mRNA expression of
ar was increased in 0.20 and 0.50mg/L groups (1.29-fold
(p¼ 0.007) and 2.13-fold (p¼ 0.043), respectively).
3.6. Effect of tebuconazole on expression of Cyp19a protein in
gonad
The expression of Cyp19a protein in gonad of zebraﬁsh at stage-
II was consistent with that of its mRNA (Fig. 5). Result illustrated
Fig. 5. Western blot analysis of the expression of protein Cyp19a in male and female
zebraﬁsh of Stage II after exposed to tebuconazole. The representative western blot of
Cyp19a expression at stage I, GAPDH was used as an internal reference. The relative
quantiﬁcation of protein expression of Cyp19a after tebuconazole exposure. Symbols of
‘\’ and ‘_’ represents female ﬁsh and male ﬁsh, respectively. VC means vehicle control.
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were reduced by 15.2% (p¼ 0.085), 57.8% (p¼ 0.006) and 66.7%
(p¼ 0.002) after treated with 0.05, 0.20 and 0.50mg/L tebucona-
zole, respectively. Meanwhile, the expressions of protein Cyp19a in
males were also down-regulated in overall but signiﬁcant down-
regulation of which was only found in 0.50mg/L treatment
(reducing by 80.1%, p¼ 0.002). Generally, it suggested that exposed
to tebuconazole inhibited the expression of protein Cyp19a in both
female and male zebraﬁsh.
4. Discussion
Tebuconazole is a triazole fungicide that has been increasingly
used in agricultural settings, leading to exposure in humans and
wildlife (Toni et al., 2011; Mercadante et al., 2014; Bernabo et al.,
2016). Limited studies have been performed so far to evaluate the
molecular effects of tebuconazole in male and female species
(Slotkin et al., 2008; Mu et al., 2015). In the present study, three
developmental stages of zebraﬁsh were used to assess the repro-
ductive and endocrine effects of tebuconazole.
Tissue-speciﬁc bioaccumulation of adult zebraﬁsh displayed
that tebuconazole was signiﬁcantly higher in gonads than in other
tissues (except liver). Previous studies have suggested that accu-
mulation of xenobiotics in gonads might be associated with
endocrine disorders or reproductive dysfunction (Wang et al.,
2015a). Consistent with accumulated values, GSI was signiﬁcantly
reduced after exposed to tebuconazole at adolescence and adult life
stages. GSI is widely used as a biomarker of gonad condition in
aquatic wildlife (Wang et al., 2015b). As a response to the decreased
GSIs in males and females, in the present study, there were sig-
niﬁcant reductions in fecundity after adolescaria and adult stages
exposures. Therefore, tebuconazole might inhibit gonadal growth
of zebraﬁsh. Simultaneously, bioaccumulation test also showed the
highest enrichment of tebuconazole in liver of zebraﬁsh. In view of
general decreases of HSI both in males and females in the present
study, tebuconazole might have hepatotoxicity to zebraﬁsh.Histological results indicated that exposed to tebuconazole in
adolescence and adult life stages (sexually differentiated life stages,
i.e., Stages II and III at present study) disrupted the gonadal
development of zebraﬁsh. Tebuconazole might directly affect the
percentage of LMO–the largest oocytes in ovary, and might lead to
change in GSI value (Zhao et al., 2015). However, a previous study
reported that the decrease of GSI in zebraﬁsh ovaries was mainly
due to the signiﬁcant decrease of late vitellogenic oocytes (Zucchi
et al., 2014). In the present study, the alterations of GSI in
0.50mg/L of Stage II and 1.84mg/L of Stages III exposure groups
conformedwith the ﬁndings reported by Zhao et al. (2015). Growth
andmaintenance of gonads are regulated by steroid hormones, and
signiﬁcant correlations have been established between lower ste-
roid levels and reduction of GSI (Liu et al., 2011;Wang et al., 2015b).
Consistent with the reduction of GSI, E2 levels were diminished in
the present study. In addition, various factors (e.g. hormones and
genes) are differentially expressed throughout follicle development
and play important roles in regulating oocytes development
(Tokarz et al., 2013; Clelland and Peng, 2009). The present ﬁndings
demonstrated that tebuconazole signiﬁcantly altered the balance
between estrogens and androgens in both female and male
zebraﬁsh. Decreases in E2/T ratio might further lead to a delay in
ovarian development and a consequent decline in fecundity, sup-
porting the anti-estrogenic effect of tebuconazole on zebraﬁsh. For
testes, exposed to tebuconazole reduced the portions of Sz in both
adolescence and adult ﬁsh, which might also contribute to the
injury in fecundity. Combined with the result of GSI reduction in
males in the present study, tebuconazole did not promote but
delayed the maturation of sperm cells in spite of the fact that
increased hormone of T was found in exposed ﬁsh. It suggested that
tebuconazole might not be an androgen function-like chemical and
the reasons remained unknown.
Additionally, histological results also indicated that exposed to
tebuconazole in juvenile stage (sexually differentiating stage, i.e.,
Stage I at present study) altered the gonadal differentiation of
zebraﬁsh, tending to result in a male sex ratio bias. As known,
zebraﬁsh is considered as a class of undifferentiated gonochoristic
species (Hoar and Randall, 1969). In recent years, evidences have
been found that some synthetic chemicals in environment could
affect the sexual differentiation of zebraﬁsh (Chen et al., 2016; Hua
et al., 2016; Lee et al., 2017; Santos et al., 2017; Delomas and
Dabrowski, 2018; Shi et al., 2018; Yang et al., 2018), playing roles
as environmental endocrine disruptors. Delomas and Dabrowski
(2018) reported that down-regulation of E2 in juvenile zebraﬁsh
induced a male-biased development. Svensson et al. (2016)
described that anti-estrogen drugs (levonorgestrel and progester-
one) could affect sexual development in juvenile ﬁsh, leading to a
male phenotype. Additionally, it was reported that 100% mutant
zebraﬁsh developed to males when gonadal aromatase gene
cyp19a1a (a key gene which regulates the synthesis of E2) was
knocked out (Lau et al., 2016). Contrarily, promoted E2 and gene
cyp19a in juvenile ﬁsh during the sex differentiation period after
exposed to perﬂuorooctanesulphonic acid (Chen et al., 2016) or
monocrotophos (Gao, 2011) produced a female-biased sex ratio.
Therefore, considering the overall down-regulations of hormone
E2, aromatase Cyp19a, and genes of cyp19a, esr1 and ers2b, as well
as male-biased development in the present study, it was deduced
that tebuconazole inhibiting E2 signal pathway might be the key
reason for the disruption of tebuconazole on sexual differentiation
of juvenile zebraﬁsh. However, the process of zebraﬁsh gonadal
differentiation is heretofore still poorly understood due to the
scarcity in available information (Santos et al., 2017). The molecular
mechanism of tebuconazole disrupting on sex differentiation of
zebraﬁsh remained further investigation.
Tebuconazole had a profound impact on the expression of genes
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hormones regulate neurogenesis, sex determination, reproductive
processes and behavior of ﬁsh (Tokarz et al., 2013). Steroidogenesis
requires the catalytic reactions of a number of enzymes including
cytochrome P450s (CYPs) and hydroxysteroid dehydrogenases
(HSDs) (Zhao et al., 2014). The mRNA expression of cytochrome
P450 19 (cyp19), 3b-hydroxysteroid dehydrogenase (hsd3b), and
11b-hydroxysteroid dehydrogenase (hsd11b) were signiﬁcantly
changed in both male and female zebraﬁsh by tebuconazole
exposure, which was consistent with the reduction of estrogen
formation. Although reductions in the expression of enzymes that
regulate the synthesis of steroid hormones were consistent with
the declines of steroid hormones in female ﬁsh after exposed to
tebuconazole, it was unclear whether tebuconazole could affect the
upstream regulation pathways of these enzymes. In addition, es-
trogen receptors (ESRs) transcripts were also reduced. ESRs
including ESR1, ESR2a and ESR2b are nuclear receptors, which play
important roles in sexual development by mediating estrogen
(Tohyama et al., 2015). The transcriptional activity of esr is regulated
in a ligand-dependent manner directly through binding of estro-
gens or anti-estrogens (Smith and O Malley, 2004; Berno et al.,
2008). Consistent with the down-regulated estrogen, transcripts
of esr1 and ers2b signiﬁcantly reduced. The present ﬁndings
demonstrated that tebuconazole signiﬁcantly changed transcripts
of genes along the HPG-axis and ultimately reduced E2.
Aromatase (Cyp19a) plays a critical role in converting androgens
into estrogens (Lou et al., 2013; Luthra, 2015). Previous studies have
demonstrated that the reduced expression of cyp19a resulted in
down-regulation of E2, probably leading to accumulation of an-
drostenedione or T (Kinoshita and Chen, 2003). In the present
study, dose-dependent reductions were observed both in tran-
scripts of cyp19a and protein levels of Cyp19a in gonad of zebraﬁsh.
Results of the present study were consistent with previous studies
on the reduction of E2 concentration in male frog by tebuconazole
(Poulsen et al., 2015). However, it was unclear how the expression
of aromatase is diminished. As reported, azole pesticides have
competitive inhibitory effects on a number of cytochrome P450
enzymes (Zhang et al., 2008; Liu et al., 2011). Previous studies
suggested that azole pesticides might be more likely to act as up-
stream enzymes inhibitors of steroidogenesis enzymes than as in-
hibitors of aromatases which are the terminal enzymes of E2
biosynthesis (Villeneuve et al., 2007; Zhang et al., 2008). This hy-
pothesis was conﬁrmed in our study by the transcriptional re-
sponses observed in gonad of female zebraﬁsh. For instance, a
signiﬁcant increase in hsd3b transcript might be regarded as a
compensatory response to the inhibitory effect on steroidogenesis
enzymes. In addition, to conﬁrm the potential inhibitory effect on
aromatase activity, down-regulated expression of cyp19a was
measured in female ﬁsh after exposed to tebuconazole. Multiple
regulatory elements have been observed in Cyp19a promoter in
zebraﬁsh (Zhao et al., 2017). Wang et al. (2015c) demonstrated that
diminished binding of the androgen-androgen receptor complex to
the androgen responsive element in Cyp19a1 promoter resulted in
suppression of aromatase expression. Similarly, down-regulated
estrogen would be expected to decrease the binding to the estro-
gen responsive elements in Cyp19a promoter. However, further
studies were needed to conﬁrm this mechanism.
5. Conclusion
In summary, our comprehensive analysis demonstrated that
exposed to tebuconazole at environmental dose could produce
anti-estrogen-like endocrine disrupting effects on zebraﬁsh.
Chronically exposed to tebuconazole could lead to a male-biased
sex differentiation in juvenile zebraﬁsh, and delay thedevelopment of germ cells in adolescence and adult zebraﬁsh,
thereby further cause adverse effects on reproduction. These anti-
estrogen-like endocrine disrupting effects might mainly attribute
to the reason that exposed to tebuconazole inhibited the expression
of aromatase Cyp19a thereby down-regulated steroid hormone E2.
However, the underlying molecular mechanisms of tebuconazole
disrupting on sex differentiation and fecundity remained to be
further studied.
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